Improving HIV prevention for sex workers using a community-based approach
Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero
This study is all about helping sex workers stay healthy by making it easier for them to use a medication called PrEP that prevents HIV, and it does this by working closely with the community to create a supportive and friendly environment for learning about and using PrEP.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10888357 on NIH RePORTER |
What this research studies
This research focuses on enhancing HIV prevention efforts among sex workers by increasing the use of pre-exposure prophylaxis (PrEP). It employs a community-empowered approach called Centering Healthcare, which fosters collaboration and interactive learning among participants. By involving sex workers in the design and implementation of the program, the study aims to create a supportive environment that promotes adherence to PrEP. The research will evaluate the feasibility and acceptability of this model for educating and navigating PrEP use within this high-risk population.
Who could benefit from this research
Good fit: Ideal candidates for this research are sex workers who are at high risk for HIV and interested in preventive measures.
Not a fit: Patients who are not engaged in transactional sex or who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce new HIV infections among sex workers by improving access to and adherence to PrEP.
How similar studies have performed: Previous research has shown that community-empowered interventions can effectively reduce HIV risk in similar populations, suggesting a promising approach.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Singer, Randi Beth — University of Illinois at Chicago
- Study coordinator: Singer, Randi Beth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.